Dr. Michael Daneshvar is a fellowship trained Urologic Oncologist from the National Cancer Institute (NCI)/National Institutes of Health (NIH). He specializes in both robotic and open surgery for the treatment of bladder, kidney, prostate, penile, testis, and adrenal cancer. His research interests include hereditary diseases and genomic alterations in genitourinary cancer. In addition, he is well published and has an interest in novel imaging techniques (artificial intelligence, PSMA), focal therapy and ablation of prostate cancer.